Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrimethamine + sulfadiazine + folinate for fetal toxoplasmosis
jRCTs071180094Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pyrimethamine, Sulfadiazine and folinic acid in congenital toxoplasmosis, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Incidence of infection at birth. Started Jun 2019; status: recruiting.
02
Drugs
pyrimethamineSulfadiazinefolinic acid
03
Conditions
congenital toxoplasmosis
Beyond the preview
Go deeper on jRCTs071180094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180094.